Foerster Friedrich, Galle Peter Robert
Department of Internal Medicine I, University Medical Center Mainz, Germany.
JHEP Rep. 2019 May 28;1(2):114-119. doi: 10.1016/j.jhepr.2019.04.005. eCollection 2019 Aug.
The management of hepatocellular carcinoma (HCC) has become ever more demanding. To evaluate the available evidence and to give clinicians the best guidance, all major hepatology societies have developed guidelines for HCC. Recently, updated versions have been published by the American, the Asian Pacific, and the European societies. This article presents a comparison of these three guidelines summarising both common ground and differences. Moreover, it highlights areas of ongoing research which will make yet another round of updates of the guidelines necessary in the near future.
肝细胞癌（HCC）的管理要求越来越高。为了评估现有证据并为临床医生提供最佳指导，所有主要的肝病学会都制定了HCC指南。最近，美国、亚太地区和欧洲学会都发布了更新版本。本文对这三个指南进行了比较，总结了共同点和差异。此外，还强调了正在进行的研究领域，这些领域将使得在不久的将来有必要对指南进行新一轮的更新。
